A fluorescent version of the bradykinin B2 receptor antagonist B-9430: Pharmacological characterization and use in live cell imaging

Peptides

Volumn 29, Issue 9, 2008, Pages 1626-1630

  Bawolak, Marie Thérèse ^a   Gera, Lajos ^b   Bouthillier, Johanne ^a   Stewart, John M ^b   Adam, Albert ^c   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B 10330; B 10380; B 9430; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING COMPETITION; BIOASSAY; BLOOD VESSEL REACTIVITY; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; JUGULAR VEIN; LIVE CELL IMAGING; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; BIOLOGICAL ASSAY; BIOTIN; BRADYKININ; FLUORESCEINS; FLUORESCENT DYES; HUMANS; KIDNEY; RABBITS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; UMBILICAL VEINS;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 49249103594     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.05.007     Document Type: Article

References (12)

1. 2 receptor. J Pharmacol Exp Ther 275 (1995) 1623-1630
2. 8 ]-bradykinin): pharmacologic profile and effective induction of receptor degradation. J Pharmacol Exp Ther 323 (2007) 534-546
3. Gera L., and Stewart J.M. A new class of bradykinin antagonists containing indanylglycine. Immunopharmacology 33 (1996) 174-177
4. 2 receptor. Hypertension 35 (2000) 1319-1325
5. 1 receptor. Br J Pharmacol 131 (2000) 885-892
6. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57 (2005) 27-77
7. 1 receptors. Peptides 29 (2008) 606-612
8. 2 receptors. Br J Pharmacol 150 (2007) 369-379
9. Pan W., Kastin A.J., Gera L., and Stewart J.M. Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci Lett 307 (2001) 25-28
10. Stewart J.M., Gera L., Hanson W., Zuzack J.S., Burkard M., McCullough R., et al. A new generation of bradykinin antagonists. Immunopharmacology 33 (1996) 51-60
11. Uknis A.B., de la Cadena R.A., Janardham R., Sartor R.B., Whalley E.T., and Colman R.W. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat. Inflamm Res 50 (2001) 140-155
12. Velarde V., Ullian M.E., Morinelli T.A., Mayfield R.K., and Jaffa A.A. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol 277 (1999) C253-C261